Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES SANOFI INDIA DIVIS LABORATORIES/
SANOFI INDIA
 
P/E (TTM) x 66.0 31.0 212.7% View Chart
P/BV x 7.1 15.4 46.4% View Chart
Dividend Yield % 0.9 7.0 12.4%  

Financials

 DIVIS LABORATORIES   SANOFI INDIA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
SANOFI INDIA
Dec-22
DIVIS LABORATORIES/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs4,6417,939 58.5%   
Low Rs2,7305,454 50.1%   
Sales per share (Unadj.) Rs292.61,202.8 24.3%  
Earnings per share (Unadj.) Rs68.7269.5 25.5%  
Cash flow per share (Unadj.) Rs81.6287.7 28.4%  
Dividends per share (Unadj.) Rs30.00570.00 5.3%  
Avg Dividend yield %0.88.5 9.6%  
Book value per share (Unadj.) Rs480.9527.0 91.3%  
Shares outstanding (eoy) m265.4723.03 1,152.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.65.6 226.2%   
Avg P/E ratio x53.724.9 215.9%  
P/CF ratio (eoy) x45.223.3 194.0%  
Price / Book Value ratio x7.712.7 60.3%  
Dividend payout %43.7211.5 20.6%   
Avg Mkt Cap Rs m978,378154,224 634.4%   
No. of employees `000NANA-   
Total wages/salary Rs m9,7504,059 240.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,67527,701 280.4%  
Other income Rs m3,447730 472.1%   
Total revenues Rs m81,12228,431 285.3%   
Gross profit Rs m23,6918,349 283.8%  
Depreciation Rs m3,432419 819.0%   
Interest Rs m2017 115.3%   
Profit before tax Rs m23,6868,643 274.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,4532,437 223.7%   
Profit after tax Rs m18,2346,206 293.8%  
Gross profit margin %30.530.1 101.2%  
Effective tax rate %23.028.2 81.6%   
Net profit margin %23.522.4 104.8%  
BALANCE SHEET DATA
Current assets Rs m97,43736,121 269.8%   
Current liabilities Rs m15,33127,425 55.9%   
Net working cap to sales %105.731.4 336.7%  
Current ratio x6.41.3 482.6%  
Inventory Days Days8117 7.2%  
Debtors Days Days84217 4,951.7%  
Net fixed assets Rs m51,12812,148 420.9%   
Share capital Rs m531230 230.8%   
"Free" reserves Rs m127,14011,906 1,067.9%   
Net worth Rs m127,67112,136 1,052.0%   
Long term debt Rs m00-   
Total assets Rs m148,56548,279 307.7%  
Interest coverage x1,209.5509.4 237.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.6 91.1%   
Return on assets %12.312.9 95.3%  
Return on equity %14.351.1 27.9%  
Return on capital %18.671.4 26.0%  
Exports to sales %85.714.1 607.8%   
Imports to sales %19.814.6 135.9%   
Exports (fob) Rs m66,5373,904 1,704.3%   
Imports (cif) Rs m15,3784,037 381.0%   
Fx inflow Rs m66,5373,904 1,704.3%   
Fx outflow Rs m15,7154,037 389.3%   
Net fx Rs m50,822-133 -38,284.1%   
CASH FLOW
From Operations Rs m24,5973,987 616.9%  
From Investments Rs m-27,0766,509 -416.0%  
From Financial Activity Rs m-7,972-15,827 50.4%  
Net Cashflow Rs m-10,451-5,331 196.0%  

Share Holding

Indian Promoters % 51.9 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 36.7 28.8 127.5%  
FIIs % 14.9 6.3 235.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 39.6 121.4%  
Shareholders   354,482 62,870 563.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Sanofi India Share Price Performance

Period Divis Laboratories Sanofi India S&P BSE HEALTHCARE
1-Day 2.14% 2.06% 1.18%
1-Month -2.15% -8.09% -0.75%
1-Year 22.51% 44.45% 61.82%
3-Year CAGR -1.38% 0.97% 18.16%
5-Year CAGR 15.77% 7.07% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

Sanofi India paid Rs 570.0, and its dividend payout ratio stood at 211.5%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.